Donepezil SR 23 mg Tablets BE study [Study Per­for­mance]

posted by madhavaraob – 2010-07-07 09:27 (5834 d 13:38 ago) – Posting: # 5597
Views: 14,942

Dear all,

We are planning to conduct a bioequivalence study on Donepezil SR 23 mg tablets in comparision with 10 mg IR tablets for US regulatory. We would like to know whether this study is feasible to be conducted in healthy population or in patients?
If the study need to be conducted in patients, what is the severity of the diseased condition (mild/moderate/severe) to be selected?

With Regards,

Madhav

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
338 visitors (0 registered, 338 guests [including 18 identified bots]).
Forum time: 23:05 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5